Original article

DOI: 10.1016/j.gastre.2021.08.006

SARS-CoV-2 vaccine acceptance among gastroenterologists and inflammatory bowel disease patients: VACUNEII project

Aceptación de la vacuna frente a SARS-CoV-2 entre gastroenterólogos y pacientes con enfermedad inflamatoria intestinal: proyecto VACUNEII

Descargar PDF

Rocío Ferreiro-Iglesiasa,b,1,

Autor para correspondencia

rocioferstg@hotmail.com

Corresponding author.

, Alejandro Hernández-Cambac,1, Ruth Serrano Labajosd, Iago Rodríguez-Lagoe,f, Yamile Zabanag,h, Manuel Barreiro-de Acostaa,b, on behalf of Young Group of Geteccu, ACCU Spain

a Gastroenterology Department, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain

b Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain

c Gastroenterology Department, Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain

d The Spanish Confederation of Crohn's & Colitis Associations (ACCU Spain), Madrid, Spain

e Gastroenterology Department, Hospital de Galdakao, Galdakao, Spain

f Biocruces Bizkaia Health Research Institute, Galdakao, Spain

g Gastroenterology Department, Hospital Universitari Mútua Terrassa, Barcelona, Spain

h Center for Biomedical Research and Network in Liver and Digestive Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain

Ver resumen